Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The First/Second Stage of Open Clinical Examination: Application of Novel Bone Substitute (ALBO-OS) in Patients With Periodontal Disease or Have a Need for Alveolar Preservation

NCT07500961 is registered in ClinicalTrials.gov with Albos d.o.o. Beograd as lead sponsor.

NCT NCT07500961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07500961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The First/Second Stage of Open Clinical Examination: Application of Novel Bone Substitute (ALBO-OS) in Patients With Periodontal Disease or Have a Need for Alveolar Preservation
Lead sponsor
Albos d.o.o. Beograd
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 1, 2026
Completion date
July 1, 2027
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

periodontitis